The U.S. Supreme Court today rejected an appeal by drugmaker Pfizer over a retrial of punitive damage claims in the case of an Arkansas woman who developed breast cancer after taking a hormone replacement drug. Pfizer wanted not just a retrial of punitive damages, but also of the $2.7 million in compensatory damages ordered for Donna Scroggin.